Valuation: Burning Rock Biotech Limited

Market Cap 671M 99.14M 87.15M 81.13M 74.5M 140M 9.51B 142M 964M 377M 4.69B 372M 364M 16.23B P/E 2024
-1.46x
P/E 2025 -27.1x
Enterprise Value 234M 34.5M 30.33M 28.24M 25.93M 48.69M 3.31B 49.33M 336M 131M 1.63B 130M 127M 5.65B EV / Sales 2024
0.06x
EV / Sales 2025 2x
Free-Float
61.34%
Yield 2024 *
-
Yield 2025 -
1 day+5.03%
1 week-6.65%
Current month+12.31%
1 month+13.66%
3 months-50.68%
6 months-73.71%
Current year-53.35%
1 week 8.95
Extreme 8.95
9.5
1 month 8.06
Extreme 8.06
12.89
Current year 6.79
Extreme 6.79
41.72
1 year 5.31
Extreme 5.3109
41.72
3 years 2.18
Extreme 2.18
41.72
5 years 2.18
Extreme 2.18
247.5
10 years 2.18
Extreme 2.18
397.5
Manager TitleAgeSince
Corporate Officer/Principal - 2013-12-31
Chief Executive Officer 48 2013-12-31
Director of Finance/CFO - 2024-09-26
Director TitleAgeSince
Chairman 48 -
Director/Board Member 55 2014-05-31
Director/Board Member 63 2016-07-31
Date Insider Type Main position Quantity % Market Cap.
6/26/26 Buy

Chief Executive Officer

24,900 0.0283%
3/31/26 Buy

Chief Executive Officer

314,870 0.3584%
3/18/26
Northern Light Venture Capital Development Ltd.
OtherCompany 11,880,245 13.5213%
Change 5-day change 1-year change 3-year change Capi.($)
+5.03%-6.65%+38.24%-53.69% 94.39M
-1.01%-1.84%+18.40%+6.49% 9.74B
+0.94%+6.76%+20.29%+11.38% 1.35B
+5.82%-3.76% - - 1.25B
0.00%+1.49%+5.83%-9.82% 1.06B
+6.58%+0.48%+43.09%+23.92% 571M
+3.07%-3.67%-25.88%-53.67% 561M
-0.28%0.00%-11.94%-10.55% 413M
-0.38%-10.67%+86.90%+124.50% 379M
+2.55%-3.01%-59.14%-82.45% 240M
Average +2.24%-1.99%+12.87%-4.88% 1.57B
Weighted average by Cap. +0.33%-2.13%+16.67%+4.83%

Financials

2024 2025
Net sales 516M 76.17M 66.96M 62.33M 57.25M 107M 7.3B 109M 741M 289M 3.61B 286M 280M 12.47B 540M 79.68M 70.05M 65.2M 59.88M 112M 7.64B 114M 775M 303M 3.77B 299M 293M 13.04B
Net income -347M -51.19M -45M -41.89M -38.47M -72.23M -4.91B -73.19M -498M -194M -2.42B -192M -188M -8.38B -55.35M -8.17M -7.18M -6.69M -6.14M -11.53M -784M -11.69M -79.5M -31.05M -387M -30.68M -30.02M -1.34B
Net Debt -474M -69.95M -61.49M -57.24M -52.57M -98.71M -6.71B -100M -680M -266M -3.31B -263M -257M -11.45B -438M -64.63M -56.82M -52.89M -48.57M -91.21M -6.2B -92.41M -629M -246M -3.06B -243M -237M -10.58B
Logo Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Employees
667
Date Price Change Volume
26-07-27 US$9.400 +5.03% 457
26-07-23 US$8.950 -2.08% 6,782
26-07-22 US$9.140 -3.28% 18,686
26-07-21 US$9.450 -6.16% 6,819